2026 Q3 Portfolio Activity
In 2026 Q3, Velan Capital Investment Management LP maintained a portfolio of 57 distinct positions. The most significant new addition was EDGEWISE THERAPEUTICS INC, now representing 1.33% of the total fund value. They heavily accumulated shares in EDESA BIOTECH INC, increasing the position by 54.9%. The fund also reduced its exposure to TENAX THERAPEUTICS INC by 87.5%.
Position History
hover any row below to update
Loading…
Total Positions
57
Quarter
2026 Q3
Top Holding
PRAX (21.3%)
Top 10 Concentration
79.8%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-50 of 57
Velan Capital Investment Management LP Full Holdings List — 2026 Q3
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
PRAX
PRAXIS PRECISIO...
|
Healthcare | 21.30% | 18.10% |
#1
Prev: #1
|
6.5 |
—
|
-12,181 | -13.7% |
P
S
|
76,600 | $22,308,218 | 2023 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
IMMX
IMMIX BIOPHARMA...
|
Healthcare | 10.78% | 6.81% |
#2
2
Prev: #4
|
6.5 |
—
|
no change | no change |
P
S
|
1,085,000 | $11,289,425 | 2025 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
TARA
PROTARA THERAPE...
|
Healthcare | 8.28% | 6.62% |
#3
2
Prev: #5
|
5.3 |
—
|
no change | no change |
P
S
|
2,844,652 | $8,676,189 | 2024 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
STRO
SUTRO BIOPHARMA...
|
Healthcare | 7.84% | 10.36% |
#4
1
Prev: #3
|
4.1 |
—
|
-2,122 | -0.4% |
P
S
|
510,038 | $8,216,712 | 2024 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ABVX
ABIVAX SA
|
Healthcare | 6.20% | 5.33% |
#5
1
Prev: #6
|
4.0 |
—
|
no change | no change |
P
S
|
65,630 | $6,498,683 | 2025 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
MPLT
MAPLIGHT THERAP...
|
Healthcare | 6.08% | 10.76% |
#6
4
Prev: #2
|
4.9 |
—
|
131,810 | 26.7% |
P
S
|
624,703 | $6,365,724 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
AVR
ANTERIS TECHNOL...
|
Healthcare | 5.19% | 4.20% |
#7
1
Prev: #8
|
3.1 |
—
|
no change | no change |
P
S
|
700,000 | $5,439,000 | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
EDSA
EDESA BIOTECH I...
|
Healthcare | 5.15% | 4.10% |
#8
1
Prev: #9
|
5.1 |
—
|
454,545 | 54.9% |
P
S
|
1,282,045 | $5,397,409 | 2025 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
AVTX
AVALO THERAPEUT...
|
Healthcare | 4.75% | 3.65% |
#9
2
Prev: #11
|
2.9 |
—
|
no change | no change |
P
S
|
324,452 | $4,973,849 | 2024 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
XNCR
XENCOR INC
|
Healthcare | 4.17% | 2.50% |
#10
2
Prev: #12
|
1.7 |
—
|
-80,000 | -31.4% |
P
S
|
175,000 | $4,366,250 | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
EVMN
EVOMMUNE INC
|
Healthcare | 3.60% | 3.65% |
#11
1
Prev: #10
|
1.9 |
—
|
5,000 | 1.1% |
P
S
|
456,255 | $3,768,666 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
EPRX
EUPRAXIA PHARMA...
|
Healthcare | 3.06% | 1.42% |
#12
5
Prev: #17
|
2.2 |
—
|
no change | no change |
P
S
|
352,000 | $3,203,200 | 2025 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
HRTX
HERON THERAPEUT...
|
Healthcare | 2.62% | 2.28% |
#13
1
Prev: #14
|
2.0 |
—
|
no change | no change |
P
S
|
8,753,290 | $2,744,156 | 2022 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
EWTX
EDGEWISE THERAP...
|
Healthcare | 1.33% | — |
#14
Prev: #—
|
4.0 |
—
|
34,250 | — |
NEW
|
34,250 | $1,390,550 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
RNTX
REIN THERAPEUTI...
|
Healthcare | 1.30% | 1.08% |
#15
4
Prev: #19
|
1.5 |
—
|
no change | no change |
P
S
|
1,700,000 | $1,366,800 | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
N/A
NASUS PHARMA LT...
|
|
Unknown | 1.27% | 0.77% |
#16
5
Prev: #21
|
1.5 |
—
|
no change | no change |
P
S
|
359,390 | $1,326,149 | — | 13F Filing | 2026-09-30 | 2026-11-16 | ||
|
QTTB
Q32 BIO INC
|
Healthcare | 0.95% | — |
#17
Prev: #—
|
3.9 |
—
|
120,000 | — |
NEW
|
120,000 | $992,400 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
NSPR
INSPIREMD INC
|
Healthcare | 0.59% | 0.06% |
#18
28
Prev: #46
|
3.2 |
—
|
776,542 | 524.2% |
P
S
|
924,680 | $617,501 | 2023 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
PTGX
PROTAGONIST THE...
|
Healthcare | 0.50% | 0.28% |
#19
6
Prev: #25
|
1.2 |
—
|
no change | no change |
P
S
|
3,700 | $521,293 | 2025 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
AARD
AARDVARK THERAP...
|
Healthcare | 0.43% | — |
#20
Prev: #—
|
3.7 |
—
|
85,868 | — |
NEW
|
85,868 | $452,524 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
NRIX
NURIX THERAPEUT...
|
Healthcare | 0.36% | 0.24% |
#21
7
Prev: #28
|
1.1 |
—
|
no change | no change |
P
S
|
16,000 | $379,360 | 2024 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
CTMX
CYTOMX THERAPEU...
|
Healthcare | 0.31% | 0.27% |
#22
4
Prev: #26
|
1.1 |
—
|
no change | no change |
P
S
|
120,000 | $326,400 | 2024 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
OVID
OVID THERAPEUTI...
|
Healthcare | 0.31% | 0.21% |
#23
6
Prev: #29
|
1.1 |
—
|
no change | no change |
P
S
|
130,000 | $323,700 | 2024 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
MLYS
MINERALYS THERA...
|
Healthcare | 0.26% | 0.18% |
#24
7
Prev: #31
|
1.1 |
—
|
no change | no change |
P
S
|
11,000 | $276,430 | 2025 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
REPL
REPLIMUNE GROUP...
|
Healthcare | 0.25% | 0.13% |
#25
10
Prev: #35
|
1.1 |
—
|
no change | no change |
P
S
|
20,000 | $264,800 | 2024 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
DTIL
PRECISION BIOSC...
|
Healthcare | 0.24% | 0.19% |
#26
4
Prev: #30
|
1.1 |
—
|
no change | no change |
P
S
|
40,000 | $250,400 | 2025 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ZLAB
ZAI LAB LTD
|
Healthcare | 0.23% | — |
#27
Prev: #—
|
3.6 |
—
|
9,000 | — |
NEW
|
9,000 | $237,060 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
CCCC
C4 THERAPEUTICS...
|
Healthcare | 0.22% | 1.62% |
#28
12
Prev: #16
|
0.1 |
—
|
-500,000 | -87.7% |
P
S
|
70,000 | $233,100 | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
MGNX
MACROGENICS INC
|
Healthcare | 0.22% | 0.17% |
#29
3
Prev: #32
|
1.1 |
—
|
no change | no change |
P
S
|
60,000 | $231,600 | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
IMNM
IMMUNOME INC
|
Healthcare | 0.21% | 0.13% |
#30
7
Prev: #37
|
1.1 |
—
|
no change | no change |
P
S
|
10,000 | $215,100 | 2025 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ANTX
AN2 THERAPEUTIC...
|
Healthcare | 0.20% | 0.12% |
#31
10
Prev: #41
|
1.1 |
—
|
no change | no change |
P
S
|
40,000 | $212,800 | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
VRDN
VIRIDIAN THERAP...
|
Healthcare | 0.20% | 0.11% |
#32
10
Prev: #42
|
1.1 |
—
|
no change | no change |
P
S
|
10,000 | $205,900 | 2025 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
CRBP
CORBUS PHARMACE...
|
Healthcare | 0.20% | 0.15% |
#33
Prev: #33
|
2.1 |
—
|
4,000 | 15.4% |
P
S
|
30,000 | $204,600 | 2024 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ENTA
ENANTA PHARMACE...
|
Healthcare | 0.19% | — |
#34
Prev: #—
|
3.6 |
—
|
15,000 | — |
NEW
|
15,000 | $197,700 | 2024 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
SCYX
SCYNEXIS INC
|
Healthcare | 0.19% | 0.10% |
#35
8
Prev: #43
|
1.1 |
—
|
no change | no change |
P
S
|
40,000 | $197,600 | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ARTV
ARTIVA BIOTHERA...
|
Healthcare | 0.17% | 0.15% |
#36
2
Prev: #34
|
1.1 |
—
|
no change | no change |
P
S
|
25,000 | $178,000 | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
RCKT
ROCKET PHARMACE...
|
Healthcare | 0.15% | 0.12% |
#37
2
Prev: #39
|
1.1 |
—
|
no change | no change |
P
S
|
60,000 | $157,800 | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
LYEL
LYELL IMMUNOPHA...
|
Healthcare | 0.14% | 0.90% |
#38
18
Prev: #20
|
0.1 |
—
|
-90,000 | -85.7% |
P
S
|
15,000 | $146,850 | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
JBIO
JADE BIOSCIENCE...
|
Healthcare | 0.13% | — |
#39
Prev: #—
|
3.6 |
—
|
10,000 | — |
NEW
|
10,000 | $140,500 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
NMRA
NEUMORA THERAPE...
|
Healthcare | 0.13% | 0.24% |
#40
13
Prev: #27
|
1.1 |
—
|
no change | no change |
P
S
|
230,000 | $137,126 | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
TENX
CALL
TENAX THERAPEUT...
|
CALL Option | 0.12% | 0.61% |
#41
17
Prev: #24
|
1.0 |
—
|
no change | no change |
P
S
|
68,700 | $129,843 | 2024 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
LRMR
LARIMAR THERAPE...
|
Healthcare | 0.10% | 0.06% |
#42
6
Prev: #48
|
1.0 |
—
|
no change | no change |
P
S
|
33,000 | $105,435 | 2024 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
KLRS
KALARIS THERAPE...
|
Healthcare | 0.07% | 0.06% |
#43
4
Prev: #47
|
1.0 |
—
|
no change | no change |
P
S
|
25,000 | $72,250 | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
GOSS
GOSSAMER BIO IN...
|
Healthcare | 0.00% | 0.01% |
Sold All 😨
(Was: #51) |
0.0 |
—
|
-70,000 | -100.0% |
CLOSED
|
— | $— | 2023 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
CNTX
CONTEXT THERAPE...
|
Healthcare | 0.00% | 0.02% |
Sold All 😨
(Was: #50) |
0.0 |
—
|
-59,700 | -100.0% |
CLOSED
|
— | $— | 2024 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
PRQR
PROQR THRAPEUTI...
|
Healthcare | 0.00% | 0.05% |
Sold All 😨
(Was: #49) |
0.0 |
—
|
-45,000 | -100.0% |
CLOSED
|
— | $— | 2024 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
XLO
XILIO THERAPEUT...
|
Healthcare | 0.00% | 0.08% |
Sold All 😨
(Was: #45) |
0.0 |
—
|
-14,285 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
QNRX
QUOIN PHARMACEU...
|
Healthcare | 0.00% | 0.10% |
Sold All 😨
(Was: #44) |
0.0 |
—
|
-32,372 | -100.0% |
CLOSED
|
— | $— | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
KPTI
KARYOPHARM THER...
|
Healthcare | 0.00% | 0.12% |
Sold All 😨
(Was: #40) |
0.0 |
—
|
-20,000 | -100.0% |
CLOSED
|
— | $— | 2024 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
TECX
TECTONIC THERAP...
|
Healthcare | 0.00% | 0.13% |
Sold All 😨
(Was: #38) |
0.0 |
—
|
-6,000 | -100.0% |
CLOSED
|
— | $— | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 |
Showing 1-50 of 57 holdings